Atlas Trials

Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment

Clinical trial NCT06361823 · UNKNOWN

Trial details

NCT number
NCT06361823
Sponsor
Capital Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Intracranial Hypertension
Start date
2024-05-01
Primary completion
2024-12-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.